Published in Hepatology on January 01, 2001
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg (2003) 1.26
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. Transplantation (2012) 0.85
Adult-to-adult Right Hepatic Lobe Living Donor Liver Transplantation. Curr Treat Options Gastroenterol (2002) 0.80
Initiation of liver transplantation in bangladesh: report on the first two successful cases. J Health Popul Nutr (2014) 0.79
Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med (2011) 0.78
Segment 4 and the left lateral segment regeneration pattern after resection of the middle hepatic vein in a living donor right hepatectomy. HPB (Oxford) (2014) 0.78
Effects of Granulocyte Colony-Stimulating Factor on Patients with Liver Failure: a Meta-Analysis. J Clin Transl Hepatol (2016) 0.75
Adult-to-adult right lobe living donor liver transplantation: comparison of endoscopic retrograde cholangiography with standard T2-weighted magnetic resonance cholangiography for evaluation of donor biliary anatomy. World J Gastroenterol (2006) 0.75
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14
Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06
Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine (1995) 1.05
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
A binding site for activation by the Bacillus subtilis AhrC protein, a repressor/activator of arginine metabolism. Mol Gen Genet (1995) 1.03
A simple new formula to assess liver weight. Transplant Proc (2003) 0.98
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant (2010) 0.98
Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res (1999) 0.98
Dissecting the molecular details of prokaryotic transcriptional control by surface plasmon resonance: the methionine and arginine repressor proteins. Biosens Bioelectron (1998) 0.98
Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer (1998) 0.97
Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis (2010) 0.97
Living related liver transplantation for acute liver failure in children. Liver Transpl Surg (1999) 0.97
Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol (1997) 0.96
Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95
Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow. Vet Surg (1995) 0.95
Infected false aneurysms of the subclavian artery: a complication in drug addicts. J Vasc Surg (1984) 0.94
Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl (2000) 0.92
Hepatic angiomyolipoma: two case reports of caudate-based lesions and review of the literature. Liver Transpl Surg (1997) 0.91
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. J Cell Biochem Suppl (1994) 0.91
An alternative technique for in situ arterial flushing in elderly liver donors with atherosclerotic occlusive disease. Transplantation (1993) 0.91
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation (1997) 0.90
Retransplantation for recurrent hepatitis C. Liver Transpl Surg (1997) 0.90
Liver transplantation in patients beyond age 60. Transplant Proc (1993) 0.89
A decrease in intracellular zinc level precedes the detection of early indicators of apoptosis in HL-60 cells. Apoptosis (2001) 0.89
Use of livers with microvesicular fat safely expands the donor pool. Transplantation (1997) 0.89
Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation (2000) 0.89
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation (1997) 0.88
Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl (2001) 0.87
Enhancing the sexual function of women living with chronic pain: a cognitive-behavioural treatment group. Pain Res Manag (2008) 0.86
The relationship of the axillary nerve to arthroscopically placed capsulolabral sutures. An anatomic study. Am J Sports Med (1998) 0.85
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II). J Surg Oncol (1994) 0.85
Probing activation of the prokaryotic arginine transcriptional regulator using chimeric proteins. J Mol Biol (1999) 0.85
Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation (2001) 0.85
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int (2000) 0.85
Brave or gullible: testing the concept that leaving susceptible parasites in refugia will slow the development of anthelmintic resistance. N Z Vet J (2008) 0.84
Reduced anastomotic bleeding using new sutures with a needle-suture diameter ratio of one. Surgery (1987) 0.84
Managing anthelmintic resistance--use of a combination anthelmintic and leaving some lambs untreated to slow the development of resistance to ivermectin. Vet Parasitol (2011) 0.83
Adult presentation of Caroli's syndrome treated with orthotopic liver transplantation. Am J Gastroenterol (1997) 0.83
Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation (1993) 0.83
Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant (2014) 0.83
Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators Inflamm (2000) 0.83
Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. J Ultrasound Med (1996) 0.82
Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells. Invest New Drugs (2014) 0.81
Dynamics of the free-living stages of sheep intestinal parasites on pasture in the North Island of New Zealand. 1. Patterns of seasonal development. N Z Vet J (2011) 0.81
Perioperative hyaluronic acid levels in orthotopic liver transplant recipient. Transplant Proc (1995) 0.81
Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation (1995) 0.81
Obviation of prereperfusion rinsing and decrease in preservation/reperfusion injury in liver transplantation by portal blood flushing. Transplantation (1994) 0.81
Accessory right hepatic duct stricture following liver transplantation. Transplantation (1991) 0.81
Multiple species of nematodes resistant to ivermectin and a benzimidazole-levamisole combination on a sheep farm in New Zealand. N Z Vet J (2008) 0.80
Splenorenal shunt closure after liver transplantation: intraoperative Doppler assessment of portal hemodynamics. Liver Transpl Surg (1997) 0.80
Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation. Clin Transplant (1997) 0.80
An in vivo assay for anti-LH-RH and anti-FSH-RH activity of inhibitory analogues of LH-RH. Endocrinology (1975) 0.80
Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. Transplant Proc (2013) 0.80
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. Transplantation (1997) 0.80
Effect of plant species on the larvae of gastrointestinal nematodes which parasitise sheep. Int J Parasitol (1998) 0.80
Drench-and-shift is a high-risk practice in the absence of refugia. N Z Vet J (2009) 0.80
Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transpl Surg (1995) 0.80
Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transpl Surg (1997) 0.80
Managing anthelmintic resistance: untreated adult ewes as a source of unselected parasites, and their role in reducing parasite populations. N Z Vet J (2008) 0.80
Preservation injury in clinical liver transplantation: incidence and effect on rejection and survival. Clin Transplant (1994) 0.80
A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg (1995) 0.80
Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation (1995) 0.80
Expression of GMP-140 (P-selectin) correlates with graft viability in cold-preserved rat livers. Transplantation (2000) 0.79
Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med (1994) 0.79
The older liver transplant candidate: what are the limits? Liver Transpl Surg (1996) 0.79
Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med (2000) 0.79
Development and spatial distribution of the free-living stages of Teladorsagia circumcincta and Trichostrongylus colubriformis on pasture: a pilot study. N Z Vet J (2011) 0.79
General guidelines for the use of tacrolimus in adult liver transplant patients. Transplantation (1996) 0.79